🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 38 of 78

  1. US 9056907

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9050311

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9050285

    Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9050300

    Surgical applications for BMP binding protein

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9051271

    Substituted pyridine derivatives useful in the treatment of cancer

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9044509

    Inhibition of HIV infection through chemoprophylaxis

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9044451

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9046520

    Serologic correlates of protection against Bacillis anthracis infection

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9044470

    Iminosugars and methods of treating viral diseases

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9044457

    Anti-DR4 agonist antibodies

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9040250

    Binding interaction of proanthocyanidins with bacteria and bacterial components

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9040233

    Methods for detecting a Mycobacterium tuberculosis infection

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9034343

    Attenuated human parainfluenza virus, methods and uses thereof

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9029344

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9028887

    Method improve spatial memory via pterostilbene administration

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9018227

    Nicotinic acetylcholine receptor agonists

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9018371

    Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9017982

    Non-wild-type organophosphorus acid anhydrolases for enzymatic decontamination

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9012647

    Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9012618

    Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9012223

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9005582

    Hyperthermia therapeutic agent delivery system

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9005633

    Psoralen-inactivated viral vaccine and method of preparation

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9005604

    Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9006203

    Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9005631

    Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9000141

    Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8999336

    Monoclonal antibodies against Orthopoxviruses

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8999352

    Genetically engineered swine influenza virus and uses thereof

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8999290

    Papillomavirus pseudoviruses for detection and therapy of tumors

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8992943

    Vaccine for protection against Shigella sonnei disease

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8993768

    Tropolone compounds for treating or preventing retroviral infection

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8993626

    Methods of treatment using sterculic acid

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8986757

    Essential oils inhibit mold on wood

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8987296

    Acridone compounds

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8987198

    Compositions and methods for treating obesity and diabetes

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8986708

    Combinations of gene deletions for live attenuated Shigella vaccine strains

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8987426

    Immunotoxin fusion proteins and means for expression thereof

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8986695

    Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8980871

    Methods of treatment for hemolysis

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8980859

    Aegyptin and uses thereof

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8980952

    Methods for treating brain swelling with a compound that blocks a non-selective cation channel

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8975231

    Bone morphogenic protein binding peptide

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8975368

    Methods for preparing linked peptide rings and peptide nanotubes obtained thereby

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8968719

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8969409

    Treatment for pulmonary hypertension

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8968729

    Date pit composition for the treatment of animals

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8961955

    Maintenance and propagation of mesenchymal stem cells

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.